Biosino Bio-Technology and Science Incorporation provided earnings guidance for the year ended December 31, 2018. For the period, the group will record a loss for the year ended 31 December 2018 as compared to a profit for the year ended 31 December 2017 despite there is an increase in revenue. Such loss is mainly attributable to an increase in cost of sales due to a change in product mix and an increase in finance costs in relation to the loans and financing obtained by the Group for its operations during the Year.